Robert S. Epstein

11.4k total citations · 3 hit papers
103 papers, 8.7k citations indexed

About

Robert S. Epstein is a scholar working on Economics and Econometrics, Orthopedics and Sports Medicine and Surgery. According to data from OpenAlex, Robert S. Epstein has authored 103 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Economics and Econometrics, 21 papers in Orthopedics and Sports Medicine and 17 papers in Surgery. Recurrent topics in Robert S. Epstein's work include Health Systems, Economic Evaluations, Quality of Life (26 papers), Bone health and osteoporosis research (21 papers) and Pharmaceutical Economics and Policy (12 papers). Robert S. Epstein is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (26 papers), Bone health and osteoporosis research (21 papers) and Pharmaceutical Economics and Policy (12 papers). Robert S. Epstein collaborates with scholars based in United States, United Kingdom and France. Robert S. Epstein's co-authors include Robert R. Verbrugge, Kimberly A. McGuigan, Michael C. Sokol, Eva Lydick, Philip D. Ross, James W. Davis, Richard D. Wasnich, Gordon Guyatt, Elizabeth F. Juniper and Roman Jaeschke and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Oncology.

In The Last Decade

Robert S. Epstein

100 papers receiving 8.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost

2005 1.4k citations Robert R. Verbrugge, Robert S. Epstein et al. profile →
Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.

1992 1.0k citations Robert S. Epstein et al. profile →
Pre-Existing Fractures and Bone Mass Predict Vertebral Fracture Incidence in Women

1991 859 citations Philip D. Ross, James W. Davis et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Robert S. Epstein	2.0k	1.8k	1.4k	1.3k	1.2k	103	8.7k
Susan E. Andrade	550 0.3×	1.3k 0.7×	1.1k 0.8×	1.0k 0.8×	246 0.2×	103	7.6k
Peter T. Donnan	291 0.1×	2.5k 1.4×	914 0.7×	671 0.5×	1.4k 1.1×	260	13.1k
Nananda F. Col	426 0.2×	934 0.5×	1.1k 0.8×	481 0.4×	245 0.2×	94	9.7k
Marc L. Berger	3.7k 1.9×	2.7k 1.5×	1.7k 1.2×	134 0.1×	1.1k 0.9×	93	10.4k
Koen Milisen	491 0.3×	1.2k 0.6×	929 0.7×	138 0.1×	1.5k 1.2×	285	9.1k
Kathleen M. Fox	3.6k 1.8×	3.3k 1.9×	604 0.4×	107 0.1×	1.5k 1.2×	169	9.3k
Karel Kostev	412 0.2×	862 0.5×	382 0.3×	270 0.2×	643 0.5×	675	7.9k
Shabbir M.H. Alibhai	600 0.3×	1.8k 1.0×	1.1k 0.8×	188 0.1×	1.6k 1.3×	437	11.4k
Yong‐Fang Kuo	630 0.3×	2.2k 1.2×	1.1k 0.8×	132 0.1×	932 0.7×	497	14.0k
Krista F. Huybrechts	565 0.3×	953 0.5×	725 0.5×	248 0.2×	186 0.1×	238	8.6k

Countries citing papers authored by Robert S. Epstein

Since Specialization

Citations

This map shows the geographic impact of Robert S. Epstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Epstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Epstein more than expected).

Fields of papers citing papers by Robert S. Epstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert S. Epstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Epstein. The network helps show where Robert S. Epstein may publish in the future.

Co-authorship network of co-authors of Robert S. Epstein

This figure shows the co-authorship network connecting the top 25 collaborators of Robert S. Epstein. A scholar is included among the top collaborators of Robert S. Epstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert S. Epstein. Robert S. Epstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Epstein, Robert S., et al.. (2025). Real-World Quantitative Insights into the Treatment Experience of Patients with Cancer in the USA with Subcutaneous Versus Intravenous Drug Delivery. Oncology and Therapy. 13(3). 695–710.

Epstein, Robert S., et al.. (2024). Time toxicity for patients receiving oral versus parenteral hypomethylating agents for myelodysplastic syndromes/neoplasms (MDS).. Journal of Clinical Oncology. 42(16_suppl). 6568–6568. 1 indexed citations

Zeidan, Amer M., Namita Joshi, Hrishikesh Kale, et al.. (2022). Impact of Hypomethylating Agent Use on Hospital and Emergency Room Visits, and Predictors of Early Discontinuation in Patients With Higher-Risk Myelodysplastic Syndromes. Clinical Lymphoma Myeloma & Leukemia. 22(9). 670–679. 4 indexed citations

Epstein, Robert S., et al.. (2022). Treatment patterns and burden of myelosuppression for patients with small cell lung cancer: A SEER‐medicare study. Cancer Treatment and Research Communications. 31. 100555–100555. 7 indexed citations

Epstein, Robert S., et al.. (2021). Real-world burden of chemotherapy-induced myelosuppression in patients with small cell lung cancer: a retrospective analysis of electronic medical data from community cancer care providers. Journal of Medical Economics. 25(1). 108–118. 19 indexed citations

Epstein, Robert S.. (2021). Payer Perspectives on Intravenous versus Subcutaneous Administration of Drugs. ClinicoEconomics and Outcomes Research. Volume 13. 801–807. 21 indexed citations

Epstein, Robert S., Upal Kunal Basu Roy, Matti Aapro, et al.. (2021). Cancer Patients’ Perspectives and Experiences of Chemotherapy-Induced Myelosuppression and Its Impact on Daily Life. Patient Preference and Adherence. Volume 15. 453–465. 22 indexed citations

Agarwal, Priya, et al.. (2020). Attitudes and Perceptions Toward COVID-19 Digital Surveillance: Survey of Young Adults in the United States. JMIR Formative Research. 5(1). e23000–e23000. 20 indexed citations

Epstein, Robert S., J. Russell Teagarden, Ali Çimen, Mark Sostek, & Tehseen Salimi. (2017). When People with Opioid-Induced Constipation Speak: A Patient Survey. Advances in Therapy. 34(3). 725–731. 14 indexed citations

10.

Charland, Scott L., Barnabie Agatep, Robert S. Epstein, et al.. (2012). PATIENT KNOWLEDGE OF PHARMACOGENETIC INFORMATION IMPROVES ADHERENCE TO STATIN THERAPY: RESULTS OF THE ADDITIONAL KIF6 RISK OFFERS BETTER ADHERENCE TO STATINS (AKROBATS) TRIAL. Journal of the American College of Cardiology. 59(13). E1848–E1848. 8 indexed citations

11.

Jha, Ashish K., Ronald E. Aubert, Jianying Yao, J. Russell Teagarden, & Robert S. Epstein. (2012). Greater Adherence To Diabetes Drugs Is Linked To Less Hospital Use And Could Save Nearly $5 Billion Annually. Health Affairs. 31(8). 1836–1846. 144 indexed citations

12.

Epstein, Robert S.. (2012). The Hypothetical Migraine Drug Comparative Effectiveness Study: A Payer’s Recommendations For Obtaining More Useful Results. Health Affairs. 31(10). 2225–2230. 4 indexed citations

13.

Stanek, Eric J., Christopher Sanders, Barnabie Agatep, et al.. (2011). A NATIONWIDE SURVEY OF ADOPTION AND PERCEPTION OF PHARMACOGENOMIC TESTING BY U.S. CARDIOLOGISTS. Journal of the American College of Cardiology. 57(14). E1283–E1283. 1 indexed citations

14.

Epstein, Robert S., Thomas P. Moyer, Ronald E. Aubert, et al.. (2010). Warfarin Genotyping Reduces Hospitalization Rates. Journal of the American College of Cardiology. 55(25). 2804–2812. 224 indexed citations

15.

Epstein, Robert S. & J. Russell Teagarden. (2010). Comparative Effectiveness And Personalized Medicine: Evolving Together Or Apart?. Health Affairs. 29(10). 1783–1787. 14 indexed citations

16.

Hudson, James I., John E. Kenzora, J. Richard Hebel, et al.. (1998). Eight-Year Outcome Associated With Clinical Options in the Management of Femoral Neck Fractures. Clinical Orthopaedics and Related Research. 348(348). 59???66–59???66. 65 indexed citations

17.

Salamone, L, R E Ferrell, Dennis M. Black, et al.. (1996). The association between vitamin D receptor gene polymorphisms and bone mineral density at the spine, hip and whole-body in premenopausal women. Osteoporosis International. 6(1). 63–68. 63 indexed citations

18.

He, Yifan, Philip D. Ross, James W. Davis, et al.. (1994). When should bone density measurements be repeated?. Calcified Tissue International. 55(4). 243–248. 15 indexed citations

19.

Epstein, Robert S., Patricia A. Deverka, Christopher G. Chute, et al.. (1992). Validation of a new quality of life questionnaire for benign prostatic hyperplasia. Journal of Clinical Epidemiology. 45(12). 1431–1445. 156 indexed citations

20.

Ross, Philip D., James W. Davis, Robert S. Epstein, & Richard D. Wasnich. (1992). Ability of vertebral dimensions from a single radiograph to identify fractures. Calcified Tissue International. 51(2). 95–99. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact